356 followers
#newupdatesneuroonc #braintumours #neuroonc EGFR amplification and classical subtype are associated with a poor response to bevacizumab in recurrent glioblastoma - https://t.co/r9d7uugSw9
EGFR amplification and classical subtype are associated with a poor response to bevacizumab in recurrent glioblastoma
Overview of attention for article published in Journal of Neuro-Oncology, January 2019